whole genome sequencing
The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.
They will provide the first access to an AI-enabled minimal residual disease test in India.
Nebula is pitching this new product as a more secure and informative alternative to mainstream consumer genomic products.